# Evaluation of a New Cardiac Pacemaker

> **NCT01700244** · NA · UNKNOWN · sponsor: **Nanostim, Inc.** · enrollment: 36 (estimated)

## Conditions studied

- Atrial Fibrillation With 2 or 3° AV or Bifascicular Bundle Branch (BBB) Block
- Normal Sinus Rhythm With 2 or 3° AV or BBB Block
- Sinus Bradycardia With Infrequent Pauses or Unexplained Syncope With EP Findings

## Interventions

- **DEVICE:** Pacemaker implant

## Key facts

- **NCT ID:** NCT01700244
- **Lead sponsor:** Nanostim, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2013-07
- **Final completion:** 2013-08
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01700244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01700244, "Evaluation of a New Cardiac Pacemaker". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01700244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*